KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Operating Margin (2016 - 2025)

Gilead Sciences' Operating Margin history spans 17 years, with the latest figure at 25.03% for Q4 2025.

  • For Q4 2025, Operating Margin fell 736.0% year-over-year to 25.03%; the TTM value through Dec 2025 reached 34.04%, up 2826.0%, while the annual FY2025 figure was 34.04%, 2826.0% up from the prior year.
  • Operating Margin reached 25.03% in Q4 2025 per GILD's latest filing, down from 42.82% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 51.77% in Q3 2021 to a low of 64.64% in Q1 2024.
  • Average Operating Margin over 5 years is 25.9%, with a median of 32.4% recorded in 2024.
  • Peak YoY movement for Operating Margin: crashed -9148bps in 2024, then skyrocketed 9820bps in 2025.
  • A 5-year view of Operating Margin shows it stood at 12.98% in 2021, then surged by 136bps to 30.68% in 2022, then dropped by -26bps to 22.66% in 2023, then skyrocketed by 43bps to 32.4% in 2024, then fell by -23bps to 25.03% in 2025.
  • Per Business Quant, the three most recent readings for GILD's Operating Margin are 25.03% (Q4 2025), 42.82% (Q3 2025), and 34.93% (Q2 2025).